Skip to content
MedsAcross

Medicine

Benzoyl peroxide and Erythromycin 50 mg/30 mg per g gel

Available on requestPrescription onlyUS FDA Cold chainGeneric name

Benzoyl peroxide and Erythromycin 50 mg/30 mg per g gel is a generic prescription medicine for topical use, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Erythromycin and Benzoyl Peroxide Topical Gel USP should then be stored under…

Key facts

Active ingredient (INN)
Benzoyl peroxide and Erythromycin
Brand
Sold under the generic name
Strength
50 mg/30 mg per g
Dosage form
Gel
Route
Topical
Packs
23.3 g, 46.6 g
Manufacturer
Rising Pharma Holdings
Origin register
US FDA, United States
Storage
Erythromycin and Benzoyl Peroxide Topical Gel USP should then be stored under refrigeration. Do not freeze. Do not freeze. Add indicated amount of room temperature 70% ETHYL ALCOHOL to vial (to the mark) and immediately shake vigorously to completely dissolve erythromycin, then immediately add this solution to gel and stir until homogeneous in appearance (1 to 1-1/2 minutes).
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
HS code (indicative)
3004.20Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
18 October 2016
Identifiers
RxCUI 244374DailyMed set ID d449d7e2-5c25-406d-87ab-30809d292476NDC 64980-328Application ANDA065385

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
23.3 g in 1 jar64980-328-01Rising Pharma Holdings18 October 2016
46.6 g in 1 jar64980-328-02Rising Pharma Holdings18 October 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 October 1984Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Benzoyl peroxide and Erythromycin

Clinical summary

Benzoyl peroxide and Erythromycin is a fixed-dose combination of a macrolide antimicrobial and a macrolide indicated for the topical treatment of acne vulgaris. It is available as kits and gel for topical use. MedsAcross supplies Benzoyl peroxide and Erythromycin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Benzoyl peroxide and Erythromycin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Benzoyl peroxide and Erythromycin 50 mg/30 mg per g gel for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.